Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Biomarkers
Medulloblastoma
Paediatric Oncology
Risk-stratification
Journal
Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
18
01
2023
accepted:
17
03
2023
revised:
17
03
2023
medline:
24
4
2023
pubmed:
5
4
2023
entrez:
4
4
2023
Statut:
ppublish
Résumé
Group 4 tumours (MB
Identifiants
pubmed: 37014508
doi: 10.1007/s00401-023-02566-0
pii: 10.1007/s00401-023-02566-0
pmc: PMC10119222
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
651-666Subventions
Organisme : Cancer Research UK
ID : DRCRPG-NOV22/100002
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V001647/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CRUK/23391
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Acta Neuropathol. 2013 Mar;125(3):373-84
pubmed: 23184418
Cancer Cell. 2017 Jun 12;31(6):737-754.e6
pubmed: 28609654
J Clin Oncol. 2011 Apr 10;29(11):1408-14
pubmed: 20823417
Acta Neuropathol. 2014 Jul;128(1):137-49
pubmed: 24791927
Cancer Res. 2022 May 16;82(10):2019-2030
pubmed: 35315927
Cancers (Basel). 2022 Jan 13;14(2):
pubmed: 35053536
Cell Rep. 2022 Aug 2;40(5):111162
pubmed: 35926460
J Clin Oncol. 2005 Nov 1;23(31):7951-7
pubmed: 16258095
Cancer Cell. 2015 Jan 12;27(1):72-84
pubmed: 25533335
Neurooncol Pract. 2017 Jun;4(2):82-97
pubmed: 31385962
Cancers (Basel). 2021 Dec 02;13(23):
pubmed: 34885186
Neuro Oncol. 2021 Jul 1;23(7):1163-1172
pubmed: 33377141
Acta Neuropathol. 2016 Jun;131(6):821-31
pubmed: 27040285
Cell Death Differ. 2022 Oct;29(10):1955-1969
pubmed: 35379950
J Clin Oncol. 2016 Dec;34(34):4151-4160
pubmed: 27863192
Nat Rev Dis Primers. 2019 Feb 14;5(1):11
pubmed: 30765705
J Clin Oncol. 2011 Apr 10;29(11):1400-7
pubmed: 20921458
Neuropathol Appl Neurobiol. 2021 Oct;47(6):736-747
pubmed: 33826763
J Clin Oncol. 2013 Aug 10;31(23):2927-35
pubmed: 23835706
J Clin Oncol. 2021 Aug 20;39(24):2685-2697
pubmed: 34110925
Lancet Oncol. 2018 Dec;19(12):1602-1616
pubmed: 30392813
Sci Rep. 2017 Oct 18;7(1):13421
pubmed: 29044166
Lancet Oncol. 2017 Jul;18(7):958-971
pubmed: 28545823
Acta Neuropathol. 2012 Apr;123(4):501-13
pubmed: 22139329
Radiology. 1969 Dec;93(6):1351-9
pubmed: 4983156
J Clin Oncol. 2021 Mar 1;39(7):822-835
pubmed: 33405951
J Clin Oncol. 2014 Mar 20;32(9):886-96
pubmed: 24493713
Nature. 2017 Jul 19;547(7663):311-317
pubmed: 28726821
Oncotarget. 2015 Nov 17;6(36):38827-39
pubmed: 26420814
Neurosurgery. 1996 Feb;38(2):265-71
pubmed: 8869053
Acta Neuropathol. 2023 Jan;145(1):97-112
pubmed: 36459208
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Nature. 2014 Jul 24;511(7510):428-34
pubmed: 25043047
Neuro Oncol. 2022 Jan 5;24(1):153-165
pubmed: 34272868
Acta Neuropathol. 2019 Aug;138(2):309-326
pubmed: 31076851
Nature. 2012 Aug 2;488(7409):49-56
pubmed: 22832581